FXR agonist 3
Based on 1 publication(s) in Google Scholar
FXR agonist 3 is an anti-NASH agent, acting by activating FXR. FXR agonist 3 inhibits COL1A1, TGF-β1, α-SMA and TIMP1 expression with anti-fibrogenic activity. FXR agonist 3 significantly reduces liver steatosis and inflammation, improves liver fibrosis level.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 96.51%
- CAS 番号: 3037847-72-3
- 分子式: C28H28BrNO4
- 分子量:522.43
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
MedChemExpress(MCE)の使用を引用している文献 FXR agonist 3
More
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| LX-2 | CC50 |
70.36 μM
Compound: 3a
|
Cytotoxicity against human LX2 cells assessed as inhibition of cell growth
Cytotoxicity against human LX2 cells assessed as inhibition of cell growth
|
[PMID: 36347091] |
FXR agonist 3 (compound 3a) (5 μM; 24 h) shows anti-fibrogenic activity, decreases multiple fibrogenic biomarkers level in LX-2 cells in a dose-dependent manner[1].
FXR agonist 3 shows cytotoxic concentration against LX2 cells with an CC50 value of 70.36 μM[1].
Metabolic stability of FXR agonist 3 in human, rat and mouse liver microsomes[1]
| Species | T1/2 (h) | CLInt (mic) (μg/min/mg) | CLInt (liver) (μg/min/mg) | Remaining Ratio (%) (T=60 min) |
| Human | 53.3 | 26.0 | 23.4 | 44.1 |
| Rat | 7.4 | 187.8 | 338.0 | 0.4 |
| Mouse | 7.4 | 187.9 | 744.1 | 39.0 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LX-2 cells
-
Concentration:0, 2.5, 5, 7.5, and 10 μM
-
Incubation Time:24 hours; with or without 2 ng/mL TGF-β1 for another 24 hr
-
Result:Decreased COL1A1, TGF-β1, α-SMA, and TIMP1 protein expressions in a dose-dependent manner.
FXR agonist 3 (200 mg/kg; p.o.; daily for 4 weeks) also exerts liver-protective and anti-fibrosis activities in bile duct ligation (BDL)-induced fibrosis rat model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 N mice fed CDAHFD diet for 16 weeks[1]
-
Dosage:200 mg/kg
-
Administration:Oral gavage; daily for 4 weeks after CDAHFD-induced
-
Result:Decreased expression of IL-1β and IL-6 in livers, indicating the liver-protective effect of 3a in CDAHFD mice may partially through inhibiting inflammasome activation.
Lowered the serum levels of biochemical markers of ALT, AST, ALP, LDH, LDL and TBiL significantly, while raised HDL and GLU levels.
-
Animal Model:C57BL/6 N mice inuced with BDL[1]
-
Dosage:200 mg/kg
-
Administration:Oral gavage; daily for 4 weeks after induced
-
Result:Protected liver from accumulated bile acid-induced injury.
Increased the expression of FXR and decreased the expression of NTCP in BDL rats.
化学情報
-
CAS 番号 3037847-72-3
-
性状 Solid
-
分子量 522.43
-
分子式 C28H28BrNO4
-
Color Light yellow to yellow
-
SMILES
COC1=C(C=C2C(CC[N+]3=C2C=C4C=CC(OC)=C(C4=C3)OCC5=CC(C)=CC=C5)=C1)OC.[Br-]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Science
2026 Feb 5;391(6785):eadz4075. PMID: 41643022
溶剤 & 溶解度
DMSO : ≥ 250 mg/mL (478.53 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (281 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9141 mL | 9.5707 mL | 19.1413 mL | 47.8533 mL |
| 5 mM | 0.3828 mL | 1.9141 mL | 3.8283 mL | 9.5707 mL | |
| 10 mM | 0.1914 mL | 0.9571 mL | 1.9141 mL | 4.7853 mL | |
| 15 mM | 0.1276 mL | 0.6380 mL | 1.2761 mL | 3.1902 mL | |
| 20 mM | 0.0957 mL | 0.4785 mL | 0.9571 mL | 2.3927 mL | |
| 25 mM | 0.0766 mL | 0.3828 mL | 0.7657 mL | 1.9141 mL | |
| 30 mM | 0.0638 mL | 0.3190 mL | 0.6380 mL | 1.5951 mL | |
| 40 mM | 0.0479 mL | 0.2393 mL | 0.4785 mL | 1.1963 mL | |
| 50 mM | 0.0383 mL | 0.1914 mL | 0.3828 mL | 0.9571 mL | |
| 60 mM | 0.0319 mL | 0.1595 mL | 0.3190 mL | 0.7976 mL | |
| 80 mM | 0.0239 mL | 0.1196 mL | 0.2393 mL | 0.5982 mL | |
| 100 mM | 0.0191 mL | 0.0957 mL | 0.1914 mL | 0.4785 mL |